Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page
- Check6 days agoChange DetectedRemoved the “Melanoma” related topics and associated MedlinePlus Genetics link from the page.SummaryDifference0.2%

- Check13 days agoChange DetectedAdded a new site revision entry for v3.5.2. Removed the previous entry for v3.5.0.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded related topics Melanoma and MedlinePlus Genetics to the study page.SummaryDifference0.2%

- Check27 days agoChange DetectedMelanoma and MedlinePlus Genetics were removed from the Related Topics section.SummaryDifference0.2%

- Check35 days agoChange DetectedAdded Melanoma as a condition keyword and included a related topics resource linking to MedlinePlus Genetics.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.5.0; removed Melanoma, related topics: MedlinePlus Genetics, and Revision: v3.4.3.SummaryDifference0.3%

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.